Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Fierce Pharma
Celcuity set to be Big Pharma 'strategic target' after approval
The biotech's Revtorpyk, also in development for prostate cancer and other solid tumors, has the potential to generate multibillion-dollar sales.
Darren Incorvaia
Jul 14, 2026 4:56pm
FDA clears Dexcom’s Stelo OTC glucose monitor for children
Jun 16, 2026 8:15am
Fierce Pharma
FDA approves Denali's Hunter syndrome drug
Mar 25, 2026 2:50pm
JenaValve secures FDA's 1st approval in aortic regurgitation
Mar 18, 2026 10:05am
Novocure gets FDA nod for device targeting pancreatic cancer
Feb 17, 2026 4:15am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
